Argent Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$2.06M Buy
23,098
+2,549
+12% +$245K 0.56% 55
2017
Q4
$2.14M Buy
20,549
+2,065
+11% +$233K 0.57% 55
2017
Q3
$2.69M Buy
18,484
+860
+5% +$117K 0.74% 41
2017
Q2
$2.29M Sell
17,624
-117
-0.7% -$14.3K 0.64% 51
2017
Q1
$2.21M Buy
17,741
+606
+4% +$72.5K 0.63% 47
2016
Q4
$1.98M Buy
17,135
+465
+3% +$51.8K 0.58% 54
2016
Q3
$1.74M Buy
16,670
+1,252
+8% +$136K 0.53% 58
2016
Q2
$1.52M Buy
15,418
+605
+4% +$62.6K 0.47% 64
2016
Q1
$1.48M Buy
14,813
+225
+2% +$23.2K 0.48% 65
2015
Q4
$1.75M Buy
14,588
+10,783
+283% +$1.25M 0.57% 54
2015
Q3
$412K Buy
3,805
+440
+13% +$54.6K 0.47% 50
2015
Q2
$389K Buy
3,365
+515
+18% +$58.9K 0.38% 61
2015
Q1
$328K Buy
2,850
+380
+15% +$45.4K 0.32% 70
2014
Q4
$276K Buy
+2,470
New +$260K 0.25% 79

Other funds holding CELG

Argent Trust's CELG Position: Q1 2018 in Review

Argent Trust increased its Celgene Corp (CELG) stake by 12% in Q1 2018, buying an estimated $245K and bringing the position to 23,098 shares worth $2.06M. The position accounts for 0.56% of the portfolio, ranked #55.

Argent Trust first reported a position in CELG in Q4 2014 and has held it in 14 quarters since. The position peaked at $2.69M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Argent Trust held 23,098 shares of Celgene Corp worth $2.06M as of Q1 2018.
  • Argent Trust bought 2,549 Celgene Corp shares in Q1 2018, an estimated $245K.
  • Celgene Corp made up 0.56% of Argent Trust's portfolio in Q1 2018, its #55 holding.
  • Argent Trust first reported a position in Celgene Corp in Q4 2014 and has held it in 14 quarters since.
  • Argent Trust's Celgene Corp position peaked at $2.69M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.